Back to ASSETMARK, INC ASSETMARK, INC

PHIOPHIO
7 quarters

Position history for ASSETMARK, INCASSETMARK, INC's holdings in PHIO PHARMACEUTICALS CORP

Yes. AssetMark holds 110 shares of PHIO (Phio Pharmaceuticals), worth $113, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. AssetMark has held PHIO since Q1 2025, across 7 quarterly 13F filings.

Current Value

$113

Current Shares

110

Total Value Change

-$30

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
110
0.0%
$1130.0%$1.03
0
2026-Q2
Unchanged
110
0.0%
$1130.0%$1.03
0
2026-Q1
Unchanged
110
0.0%
$1340.0%$1.01
0
2025-Q4
Unchanged
110
0.0%
$1160.0%$1.02
0
2025-Q3
Unchanged
110
0.0%
$2730.0%$2.36
0
2025-Q2
Unchanged
110
0.0%
$2590.0%$2.17
0
2025-Q1
New
110
-
$1430.0%$1.29
17

Other major holders of PHIO: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used